Literature DB >> 11228185

Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.

A Breborowicz1, A Polubinska, J Moberly, K Ogle, L Martis, D Oreopoulos.   

Abstract

The effect of high-molecular-weight hyaluronan (HA) on peritoneal and systemic inflammation and peritoneal permeability to water and solutes was studied during endotoxin-induced peritonitis in rats. Acute peritonitis was induced by adding lipopolysaccharide (LPS) to the dialysis fluid (Dianeal 3.86; Baxter Healthcare, Ireland, Castlebar). HA was added to the dialysis solution in a concentration of 10 mg/dL. During 4- and 8-hour dwells of the dialysis fluid, we studied the intensity of peritoneal (dialysate) and systemic (blood) inflammation (dialysate cell count and differential, cytokine and HA levels), as well as the transperitoneal transport of solutes and water. In rats, the addition of LPS to the dialysis fluid induced changes in inflammatory reaction and transperitoneal transport similar to those seen in continuous ambulatory peritoneal dialysis patients with peritonitis. During peritonitis, the addition of HA to the dialysis fluid reduced the loss of ultrafiltration, which resulted in a greater peritoneal creatinine clearance during the 8 hours of dwell (29.9 +/- 6.7 mL/8 h in the HA-LPS group versus 19.7 +/- 7.8 mL/8 h in the LPS group; P < 0.05). Dialysate interferon-gamma (INF-gamma) levels during peritonitis were greater in HA-treated animals (536.8 +/- 296.6 pg/mL in the HA-LPS group versus 169.8 +/- 137.8 pg/mL in the LPS group; P < 0.05). Dialysate elastase activity increased during peritonitis (44.4 +/- 9.3 versus 14.2 +/- 4.1 U/mL in peritonitis-free rats); during peritonitis, the increase in dialysate elastase activity was less pronounced in the rats that had HA in the dialysate (27.3 +/- 4.1 U/mL versus the LPS group; P: < 0.01). We conclude that HA added to the dialysis fluid reduces loss of ultrafiltration during peritonitis in rats. In the presence of HA dialysate, INF-gamma levels during peritonitis increased, whereas elastase activity decreased; these changes might improve the peritoneal immune reaction during peritonitis and at the same time prevent peritoneal membrane injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228185     DOI: 10.1053/ajkd.2001.22086

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way.

Authors:  Huan Chen; Mahesh Mahaseth; Yan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

2.  Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.

Authors:  Peter J Margetts; Martin Kolb; Lisa Yu; Catherine M Hoff; Clifford J Holmes; Daniel C Anthony; Jack Gauldie
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

3.  High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats.

Authors:  Yung-Yang Liu; Cheng-Hung Lee; Rejmon Dedaj; Hang Zhao; Hicham Mrabat; Aviva Sheidlin; Olga Syrkina; Pei-Ming Huang; Hari G Garg; Charles A Hales; Deborah A Quinn
Journal:  Crit Care       Date:  2008-08-08       Impact factor: 9.097

Review 4.  Regulation of synthesis and roles of hyaluronan in peritoneal dialysis.

Authors:  Timothy Bowen; Soma Meran; Aled P Williams; Lucy J Newbury; Matthias Sauter; Thomas Sitter
Journal:  Biomed Res Int       Date:  2015-10-13       Impact factor: 3.411

Review 5.  With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment.

Authors:  Elizabeth I Harper; Emma F Sheedy; M Sharon Stack
Journal:  Cancers (Basel)       Date:  2018-07-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.